8-K: Scotts Miracle-Gro Reports Q2 Results: Gross Margin Improvement Drives EBITDA Growth
Earnings Release
Scotts Miracle-Gro's Q2 2025 results show gross margin improvements driving EBITDA growth, with reaffirmed full-year guidance for the U.S. Consumer segment.
Summary
- Scotts Miracle-Gro reported a 7 percent decrease in total company sales for Q2 2025, amounting to $1.42 billion compared to $1.53 billion in the prior year.
- U.S. Consumer sales decreased by 5 percent to $1.31 billion.
- GAAP gross margin rate improved to 38.6 percent, and the non-GAAP adjusted gross margin rate improved to 39.1 percent.
- GAAP net income was $217.5 million, or $3.72 per diluted share, compared to $157.5 million, or $2.74 per diluted share, in the same quarter last year.
- Non-GAAP adjusted EBITDA for the quarter was $402.8 million, an improvement of $6.5 million over the prior year.
- Net leverage decreased to 4.41x, down from 6.95x in the prior year.
- The company reaffirms its full-year guidance for the U.S. Consumer segment net sales, adjusted gross margin, adjusted EBITDA, and free cash flow.
- Full-year revenue guidance for the Hawthorne segment is no longer being provided due to the uncertain environment in the cannabis industry.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to improved margins and reaffirmed guidance for the U.S. Consumer segment, despite a sales decline and withdrawn guidance for the Hawthorne segment. The company is also reducing debt.
Positives
- Significant improvement in GAAP and non-GAAP adjusted gross margin rates.
- Increase in GAAP and non-GAAP adjusted net income and EPS.
- Improved non-GAAP adjusted EBITDA compared to the prior year.
- Substantial reduction in net leverage.
- Strong consumer POS trends with double-digit increases in consumer takeaway.
- Reaffirmation of full-year guidance for the U.S. Consumer segment.
Negatives
- Decline in total company sales by 7 percent.
- Decrease in U.S. Consumer sales by 5 percent.
- Hawthorne segment sales decreased 51 percent for the quarter and 42 percent for the six months ended March 29, 2025.
- The company is no longer providing full-year revenue guidance for its Hawthorne segment.
Risks
- An economic downturn and economic uncertainty may adversely affect demand for the Company's products.
- The Company's operations, financial condition or reputation may be impaired if its information or operational technology systems fail to perform adequately or if it is the subject of a data breach or cyber-attack.
- The highly competitive nature of the Company's markets could adversely affect its ability to maintain or grow revenues.
- Climate change and unfavorable weather conditions could adversely impact financial results.
- Disruptions in availability or increases in the prices of raw materials, fuel or transportation costs could adversely affect the Company's results of operations.
- The Company's business is subject to risks associated with sourcing and manufacturing outside of the U.S. and risks from tariffs and/or international trade wars.
- Because of the concentration of the Company's sales to a small number of retail customers, the loss of one or more of, or significant reduction in orders from, its top customers, or a material reduction in the inventory of the Company's products that they carry, could adversely affect the Company's financial results.
Future Outlook
The company reaffirms its full-year guidance for the U.S. Consumer segment net sales, adjusted gross margin, adjusted EBITDA, and free cash flow, but is no longer providing full-year revenue guidance for its Hawthorne segment due to uncertainty in the cannabis industry.
Management Comments
- 'We have made substantial progress in the key financial metrics that support our full-year guidance,' said Jim Hagedorn, chairman and CEO.
- 'We are equally pleased with our year-to-date consumer product sales to retailers, given they are essentially flat excluding non-repeating fiscal 24 sales.'
- 'We continue to advance our fiscal 2025 financial plan focused on sustainable net sales growth, margin recovery and a stronger balance sheet,' said Mark Scheiwer, chief financial officer and chief accounting officer.
- 'We are driving significant free cash flow and debt paydown while making incremental investments in consumer activation programs.'
Industry Context
Scotts Miracle-Gro's performance is influenced by consumer spending on lawn and garden products, weather conditions, and trends in the indoor and hydroponic growing segment. The decision to withdraw guidance for the Hawthorne segment reflects ongoing challenges and uncertainties within the cannabis industry, which impacts companies providing hydroponic growing products.
Comparison to Industry Standards
- It's difficult to provide a precise comparison without knowing the specific companies Scotts Miracle-Gro considers its direct competitors.
- However, key competitors in the consumer lawn and garden market include companies like Central Garden & Pet and Spectrum Brands.
- Comparing Scotts' gross margin and EBITDA performance to these companies would provide a better understanding of its relative performance.
- In the hydroponics sector, competitors include companies like Hydrofarm and GrowGeneration.
- The decision to withdraw guidance for the Hawthorne segment suggests that Scotts Miracle-Gro is facing similar challenges as other companies in the hydroponics sector due to the volatile cannabis market.
Stakeholder Impact
- Shareholders may react positively to the improved margins and reaffirmed guidance for the U.S. Consumer segment.
- Employees may be affected by ongoing restructuring initiatives.
- Customers can expect continued investment in consumer activation programs.
- Suppliers may be impacted by changes in sourcing and manufacturing strategies.
Next Steps
- The company will discuss results during a video presentation via webcast on April 30, 2025.
- The Company expects to provide an updated outlook in early June.
Key Dates
| Date | Description |
|---|---|
| March 30, 2024 | Prior year comparative period for financial results. |
| September 30, 2024 | Date of Condensed Consolidated Balance Sheet. |
| March 29, 2025 | End of the second quarter of fiscal year 2025. |
| April 30, 2025 | Date of the news release and 8-K filing. |
Keywords
Scotts Miracle-Gro, Financial Results, Q2 2025, Gross Margin, EBITDA, Consumer Sales, Hawthorne, Guidance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.